There are unresolved issues regarding sustained virological response (SVR), tolerance and risk of rejection following antiviral therapy in liver transplantation (LT). The aim of our study was to determine efficacy, rejection risk and factors associated with SVR. HCV-infected LT patients with at leas
Associations between serum lipids and hepatitis C antiviral treatment efficacy
โ Scribed by Darmendra Ramcharran; Abdus S. Wahed; Hari S. Conjeevaram; Rhobert W. Evans; Tianyi Wang; Steven H. Belle; Leland J. Yee; for the Virahep-C Study Group
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 376 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Many studies have demonstrated in animal experiments that persistent inflammation may accelerate the development of carcinoma. In this article, the question of whether the persistent elevation of serum alanine aminotransferase (ALT) levels (which represents the inflammatory necrosis of hepatocytes)
## Background: The relationship between the recurrence of hepatocellular carcinoma (hcc) and the serum alanine aminotransferase (alt) level was studied in hepatectomized patients with hepatitis c virus (hcv)-associated cirrhosis and hcc. ## Methods: Twenty-six hepatectomized patients with hcv-ass
In hepatitis C virus (HCV) genotypes 2 and 3 patients, the high rate of relapse after 12 to 16 weeks of antiviral therapy is the main concern for shortening treatment duration. This study was undertaken to delineate predictors of relapse after short treatment in patients with undetectable HCV RNA at